YMRC
TDOC icon

Yorktown Management & Research Company’s Teladoc Health TDOC Stock Holding History

Yorktown Management & Research Company’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,300
Closed -$209K – 224
2022
Q2 		$209K Buy
+6,300
New +$268K 0.27% 168
2022
Q1 		– Sell
-2,322
Closed -$213K – 265
2021
Q4 		$213K Buy
+2,322
New +$278K 0.14% 245

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Yorktown Management & Research Company's TDOC Position: Q3 2022 in Review

Yorktown Management & Research Company sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 6,300 shares — an estimated $209K sold.

Yorktown Management & Research Company first reported a position in TDOC in Q4 2021 and held it in 2 quarters. The position peaked at $213K in Q4 2021. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Yorktown Management & Research Company reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Yorktown Management & Research Company sold 6,300 Teladoc Health shares in Q3 2022, an estimated $209K.
  • Yorktown Management & Research Company first reported a position in Teladoc Health in Q4 2021 and held it in 2 quarters.
  • Yorktown Management & Research Company's Teladoc Health position peaked at $213K in Q4 2021.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Yorktown Management & Research Company's 13F filing for Q3 2022, filed 4 Nov 2022.